Contact Living Health Integrative Medicine today to learn about our natural, root-cause weight management programs.
Unlike some health care practices, which offer both nutrition-related services and a range of other health care services, our exclusive focus is helping our clients achieve their nutrition-related health and wellness goals, with compassion and affirmation for each clients individualized journey
Full analysis #GLP1 #EmployeeBenefits #HealthcareCosts #WorkforceHealth #Aon Farheen Dam Doug Melton Lisa Stevens Laura Rissover Liz Parr Lindsay Dower, MHA Kembre Roberts, PhD Workforce-Focused Analysis on GLP-1s: Phase Two Findings aon.com To view or add a comment, sign in Novo Nordisks FDA-approved Wegovy pill, as highlighted by Ferrin Williams, PharmD MBA, marks a major shift in obesity careintroducing an oral GLP-1 option that could expand access, improve adherence, and reshape how clinicians manage chronic weight conditions
In the groundbreaking study of spironolactone in heart failure treatment, the incidence of severe hyperkalemia was 2% for those taking spironolactone compared with 1% for those taking a placebo (inactive medicine)
GLP-1 medications have also been associated with: Worsening of diabetic retinopathy Exacerbation of age-related macular degeneration Optic nerve complications, including NAION These risks dont mean you should stop taking your medication, but they do show why its important to have an eye exam before starting and regular follow-up exams while on treatment
